Ritalin Warning Label to be Strengthened

June 30, 2005

Ritalin Warning Label to be Strengthened

The FDA said today it plans to strengthen the warning label for Concerta, the popular long-acting version of Ritalin (methylpenidate) in response to reports of psychiatric and cardiovascular adverse effects. (MedPage Today)

Posted by news editor | Filed under: ADD/ADHD

More News Topics:
Breast Cancer Alternative Medicine Infectious Disease Eating Disorders Sleep Orthopedic Allergies Neurological Disorders Senior Health Heart Health Autoimmune Disorders Women's Health

All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 HealthDiaries.com. All rights reserved.